Miner Company
Columbia Cornerstone Growth Fund Q4 2025 Quarterly Portfolio Recap
U.S. equities posted a gain of 2.41% in the fourth quarter, as measured by the Russell 1000 Index. Notably, the quarter was characterized by a broadening of leadership away from the mega-cap technology stocks as value stocks outpaced their growth counterparts. Eli Lilly was another standout performer, posting strong earnings driven by its dominant position in obesity treatments.
U.S. equities posted a gain of 2.41% in the fourth quarter, as measured by the Russell 1000 Index. Notably, the quarter was characterized by a broadening of leadership away from the mega-cap technology stocks as value stocks outpaced their growth counterparts. Eli Lilly was another standout performer, posting strong earnings driven by its dominant position in obesity treatments.